Caninized anti-NGF antibodies and methods thereof
Abstract:
The present disclosure encompasses novel caninized anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotides of the invention for the treatment and/or prevention of NGF related disorders, particularly for the management of canine pain.
Public/Granted literature
Information query
Patent Agency Ranking
0/0